Articles, App Notes, Case Studies, & White Papers

  1. Reducing Total Cost Of Ownership In Media Filtration 3/20/2018

    The production of mAb and recombinant proteins has undergone significant progress in recent decades. Higher titers and increasing cell densities present challenges to upstream and downstream groups alike.

  2. Protein Analysis With Size Exclusion Chromatography (SEC) 2/20/2018

    This white paper presents fundamentals about analytical SEC and describes how our new-generation agarose-based SEC columns are used in analysis of biomolecules.

  3. Cryoport Systems Global Supply Chain Center: Ready For Launch! 6/6/2022

    Cell & gene therapies are rapidly outpacing the industry's limited manufacturing capacity. Learn more about the developing network of supply chain centers built to support this growing client base.

  4. What Sponsors Get Wrong When Selecting A CRO 3/9/2026

    Gene therapy immunogenicity requires platforms, judgment, and regulatory fluency beyond ADA norms. Relying on biologics criteria creates gaps; CGT expertise ensures reliable, interpretable results.

  5. A&M STABTEST Expands Service Offerings In Protein And Oligonucleotide Analysis With LC-MS System 2/22/2022

    CRO upgrades systems to provide regulatory compliance for large-molecule protein analysis, expanding their oligonucleotides capabilities.

  6. mRNA Vaccine Development: Planning, Workflow, Supply Chain Success 5/17/2022

    A review of insights derived from the development of mRNA-based COVID-19 vaccines and how they can be applied to accelerate progress in the manufacture of vaccines and therapeutics moving forward.

  7. Phase I Trials Global Clinical Trial Landscape – Focus On Asia Pacific 5/9/2023

    Unearth key trends in global Phase I trials, including highlights from the top therapeutic areas, indications, and biologic drug types in popular trial regions of Asia Pacific, the United States, and Europe.

  8. How Clinical Trials Work 4/4/2025

    Explore a comprehensive overview of clinical trial designs and protocols; including the four distinct phases, eligibility criteria, and essential methodologies.

  9. 3 Services Your Biopharmaceutical Supply Chain Partner Should Offer 5/31/2023

    Finding an experienced partner dedicated to reducing risk of contamination and capable of growing with you as project advances through clinical trial stages is essential.

  10. Standardization And Flexibility In Aseptic Filling

    Standardization and flexibility in aseptic filling were thought to be mutually exclusive. But what if there was a standardized system with flexibility built into the aseptic process, so you didn’t have to choose?